Skip to content
Medical Health Aged Care

CLP election proposal risks the health of Territorians

Royal Australian College of GPs 2 mins read

The Country Liberal Party’s proposal allowing pharmacists to treat 21 conditions if elected risks the health of Territorians, including misdiagnosis and incorrect treatment, warns the Royal Australian College of GPs (RACGP). 

The RACGP has written to the CLP to warn against the proposal, which would allow pharmacists to provide drugs for 21 conditions without a GP diagnosing and prescribing them to a patient. This contravenes Therapeutic Goods Administration (TGA) rules for medicines designed to protect the health of Australians. 

RACGP Northern Territory Chair Dr Sam Heard said GPs in the Northern Territory are extremely concerned. 

“The Country Liberals haven't consulted GPs in the Northern Territory, and we are extremely concerned that there has been no consideration given to the potential risks to peoples’ health – including incorrect and missed diagnosis, and incorrect treatment,” he said.  

“Patients don’t present with a diagnosis, they just have symptoms, which might be any number of conditions. For example, the symptoms of a UTI are similar to symptoms for pregnancy, STIs, cancer and undiagnosed diabetes. 

Diagnosing a patient is difficult, which is why GPs train for over 10 years. Pharmacists play an important role in dispensing and giving advice on medicines but they are not trained to diagnose patients.  

The risks associated with this approach were seen in Queensland, where a survey of more than 1,300 doctors found more than 240 cases of misdiagnosis associated with the North Queensland UTI Pharmacy Prescribing Trial. At least nine patients needed hospitalisation relating to ineffective or delayed medical treatment.  

“Were especially concerned by the number of conditions in the list requiring treatment with antibiotics. Inappropriate prescribing of antibiotics increases the risk of antibiotic resistance in the community. When this happens, simple infections can become life threatening. This is not something we can risk in the Northern Territory. The broader scope of practice for nurses and Aboriginal health practitioners that we have in the NT is already resulting in antibiotic resistance. Over the counter supply of antibiotics will make it much worse.  

Making prescription medicines easier to access should not be prioritised over access to high quality general practice care for NT patients and families. The RACGP is keen to discuss real solutions to improve access to GPs in the Northern Territory with the Country Liberals. 

“The RACGP encourages the next Territory government to focus on improving access to high quality general practice care for Territorians and ensuring the sustainability of general practice. Territorians deserve high quality primary healthcare that they can trust, not bandaid solutions that risk peoples health.” 

~ENDS


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

Contact: 03 8699 0992media@racgp.org.au

Follow us on Twitter: @RACGP and Facebook.

More from this category

  • Medical Health Aged Care
  • 31/10/2024
  • 17:55
Kyowa Kirin Co., Ltd.

Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company

Masashi Miyamoto to be named Chairman and CEO Abdul Mullick to be named President and COO Changes designed to further deliver on company’s 2030…

  • Contains:
  • Medical Health Aged Care
  • 31/10/2024
  • 12:10
MannKind

First Site Initiated in Australia for MannKind’s Phase 3 Clinical Trial Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease

ICoN-1 study presentation planned November 1 at NTM Symposium AustraliaStudy is cleared by health authorities to proceed in Australia, U.S., Japan and South Korea, with Taiwan anticipated by end of year DANBURY, Conn., Oct. 30, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that it has initiated its first site for its Phase 3 clinical trial evaluating efficacy and safety of Clofazimine Inhalation Suspension for the treatment of nontuberculous mycobacterial (NTM) lung disease. The study,…

  • Business Company News, Medical Health Aged Care
  • 31/10/2024
  • 11:03
Firebrick Pharma

Agreement Signed to Market Nasodine to Healthcare Professionals in Singapore

Firebrick Pharmais pleased to announce that it has executed a Marketing Representation Agreement (the “Agreement”) with Singapore-based, Innorini, trading as Innorini Life Sciences (“Innorini”). The initial term of the Agreement is one year with the option to renew for subsequent one-year terms by mutual agreement. Under the Agreement, Innorini will undertake “Marketing Services” commencing 1 November 2024. The Marketing Services comprise sampling and promotion of Nasodine® Nasal Spray (“Nasodine”) to General Practitioners (“GPs”) and hospital-based doctors and pharmacists (collectively “HCPs”) in Singapore. In addition to building awareness and support of Nasodine by HCPs, Innorini will be expected to sell Nasodine…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.